Credit Agricole’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.6M Sell
785,099
-105,679
-12% -$6.16M 0.13% 127
2025
Q4
$48M Buy
890,778
+61,680
+7% +$2.97M 0.11% 145
2025
Q3
$37.4M Buy
+829,098
New +$38.7M 0.1% 153
2025
Q1
$47.6M Sell
781,122
-822,494
-51% -$47.9M 0.15% 118
2024
Q4
$90.7M Buy
1,603,616
+1,156,270
+258% +$64.6M 0.27% 67
2024
Q3
$23.1M Buy
447,346
+42,871
+11% +$2.01M 0.1% 154
2024
Q2
$16.8M Buy
404,475
+267,631
+196% +$12M 0.09% 157
2024
Q1
$6.61M Buy
136,844
+70,756
+107% +$3.6M 0.07% 221
2023
Q4
$3.39M Buy
66,088
+35,409
+115% +$1.86M 0.04% 252
2023
Q3
$1.78M Buy
30,679
+10,689
+53% +$655K 0.03% 289
2023
Q2
$1.28M Buy
19,990
+1,854
+10% +$124K 0.02% 279
2023
Q1
$1.26M Buy
18,136
+3,864
+27% +$273K 0.03% 261
2022
Q4
$1.03M Sell
14,272
-153
-1% -$11.5K 0.02% 295
2022
Q3
$1.03M Sell
14,425
-127
-0.9% -$9.21K 0.02% 297
2022
Q2
$1.12M Buy
14,552
+5,998
+70% +$457K 0.03% 292
2022
Q1
$625K Sell
8,554
-8,658
-50% -$581K 0.01% 344
2021
Q4
$1.07M Sell
17,212
-13,538
-44% -$794K 0.02% 288
2021
Q3
$1.82M Buy
30,750
+12,794
+71% +$843K 0.03% 241
2021
Q2
$1.2M Buy
17,956
+4,752
+36% +$310K 0.02% 249
2021
Q1
$834K Buy
13,204
+9,362
+244% +$582K 0.02% 242
2020
Q4
$238K Sell
3,842
-475
-11% -$29.2K 0.01% 308
2020
Q3
$261K Buy
4,317
+152
+4% +$9.15K 0.01% 262
2020
Q2
$245K Sell
4,165
-1,183
-22% -$70.8K 0.02% 248
2020
Q1
$298K Buy
5,348
+3,470
+185% +$212K 0.03% 234
2019
Q4
$121K Sell
1,878
-1,122
-37% -$64.3K 0.01% 267
2019
Q3
$152K Hold
3,000
0.01% 339
2019
Q2
$136K Hold
3,000
0.01% 337
2019
Q1
$143K Sell
3,000
-83,361
-97% -$4.15M 0.01% 343
2018
Q4
$4.49M Sell
86,361
-6,750
-7% -$363K 0.25% 104
2018
Q3
$5.78M Buy
93,111
+11,250
+14% +$668K 0.28% 83
2018
Q2
$4.53M Buy
81,861
+3,090
+4% +$167K 0.32% 75
2018
Q1
$4.98M Buy
78,771
+8,120
+11% +$522K 0.34% 79
2017
Q4
$4.33M Sell
70,651
-793,011
-92% -$49.6M 0.29% 82
2017
Q3
$55M Sell
863,662
-90,701
-10% -$5.3M 0.19% 131
2017
Q2
$53.2M Sell
954,363
-758,457
-44% -$41.3M 0.17% 150
2017
Q1
$93.1M Buy
1,712,820
+126,688
+8% +$6.95M 0.28% 76
2016
Q4
$92.7M Sell
1,586,132
-18,695
-1% -$1.02M 0.3% 74
2016
Q3
$86.5M Sell
1,604,827
-188,198
-10% -$12.1M 0.28% 76
2016
Q2
$132M Sell
1,793,025
-470,428
-21% -$33.2M 0.51% 38
2016
Q1
$145M Buy
2,263,453
+285,810
+14% +$18M 0.68% 27
2015
Q4
$136M Buy
1,977,643
+85,958
+5% +$5.68M 0.64% 29
2015
Q3
$112M Buy
1,891,685
+263,386
+16% +$16.7M 0.56% 34
2015
Q2
$108M Buy
1,628,299
+562,989
+53% +$37.1M 0.51% 34
2015
Q1
$68.7M Buy
1,065,310
+293,825
+38% +$18.4M 0.31% 68
2014
Q4
$45.7M Buy
771,485
+4,087
+0.5% +$230K 0.2% 120
2014
Q3
$39.3M Sell
767,398
-38,434
-5% -$1.92M 0.17% 144
2014
Q2
$39.1M Sell
805,832
-136,555
-14% -$6.73M 0.17% 149
2014
Q1
$49M Buy
942,387
+342,626
+57% +$18.2M 0.2% 136
2013
Q4
$31.9M Sell
599,761
-28,260
-4% -$1.44M 0.13% 204
2013
Q3
$29.1M Buy
+628,021
New +$27.6M 0.13% 207

Other funds holding BMY

Credit Agricole's BMY Position: Q1 2026 in Review

Credit Agricole reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, selling an estimated $6.16M and leaving 785,099 shares worth $47.6M. The position accounts for 0.13% of the portfolio, ranked #127.

Credit Agricole first reported a position in BMY in Q3 2013 and has held it in 50 quarters since. The position peaked at $145M in Q1 2016. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Credit Agricole held 785,099 shares of Bristol-Myers Squibb worth $47.6M as of Q1 2026.
  • Credit Agricole sold 105,679 Bristol-Myers Squibb shares in Q1 2026, an estimated $6.16M.
  • Bristol-Myers Squibb made up 0.13% of Credit Agricole's portfolio in Q1 2026, its #127 holding.
  • Credit Agricole first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 50 quarters since.
  • Credit Agricole's Bristol-Myers Squibb position peaked at $145M in Q1 2016.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.